Valuation : Sirnaomics Ltd.

Market Cap 52.77M 414M 45.41M 42.73M 39.03M 73.01M 4.98B 73.21M 505M 196M 2.56B 198M 194M 8.24B P/E 2024
-0.67x
P/E 2025 -6.46x
Enterprise Value 48.57M 381M 41.79M 39.32M 35.92M 67.2M 4.59B 67.38M 465M 180M 2.35B 182M 178M 7.58B EV / Sales 2024
24.1x
EV / Sales 2025 -
Free-Float
73.19%
Yield 2024 *
-
Yield 2025 -
1 day-3.55%
1 week-3.80%
Current month+0.80%
1 month-5.00%
3 months-26.64%
6 months-36.03%
Current year-50.46%
1 week 3.65
Extreme 3.65
4.08
1 month 3.65
Extreme 3.65
4.7
Current year 3.65
Extreme 3.65
10.72
1 year 3.65
Extreme 3.65
22.78
3 years 2.35
Extreme 2.35
54.25
5 years 2.35
Extreme 2.35
101
10 years 2.35
Extreme 2.35
101
Manager TitleAgeSince
Chief Executive Officer 48 2024-11-05
Director of Finance/CFO 35 2021-08-31
Compliance Officer 73 2019-12-31
Director TitleAgeSince
Chairman 48 2025-11-30
Director/Board Member 56 2025-02-16
Director/Board Member 50 2025-07-02
Date Insider Type Main position Quantity % Market Cap. Importance
3/30/26 Other 38,000 0.0354%
11/24/24 Other

Chief Executive Officer

12,067 0.0138%
6/5/24 Other

Executive/Senior Manager

5,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-3.55%-3.80%-74.62%-92.24% 52.77M
-1.79%-2.27%+43.23%+88.96% 67.98B
-2.06%-0.18%+39.67%+86.44% 64.94B
-0.31%+6.54%-12.96%+378.92% 27.58B
+0.86%+1.65%-7.74%-14.95% 26.06B
-3.00%-2.90%+33.13%+12.54% 25.74B
-1.46%+0.42%+23.61%-18.61% 20.09B
-2.96%-15.21%+216.20%+368.10% 17.16B
-1.49%-4.88%-6.60%+531.89% 14.92B
-0.20%+8.37%+55.78%+164.98% 14.62B
Average -1.60%-0.15%+30.97%+150.60% 27.92B
Weighted average by Cap. -1.52%+0.18%+38.35%+137.31%

Financials

2024 2025
Net sales 1.78M 13.94M 1.53M 1.44M 1.31M 2.46M 168M 2.47M 17.01M 6.6M 86.13M 6.68M 6.53M 277M -
Net income -51.38M -403M -44.22M -41.6M -38M -71.09M -4.85B -71.28M -492M -191M -2.49B -193M -189M -8.02B -14.4M -113M -12.39M -11.66M -10.65M -19.93M -1.36B -19.98M -138M -53.47M -698M -54.08M -52.91M -2.25B
Net Debt -3.71M -29.1M -3.19M -3M -2.74M -5.13M -350M -5.15M -35.5M -13.78M -180M -13.94M -13.63M -579M -4.2M -32.96M -3.62M -3.4M -3.11M -5.82M -397M -5.83M -40.22M -15.61M -204M -15.79M -15.44M -656M
Logo Sirnaomics Ltd.
Sirnaomics Ltd. is an investment holding company. The Company and its subsidiaries are clinical-stage biotechnology companies that are engaged in developing and commercializing ribonucleic acid interference (RNAi) technology and multiple therapeutics. The Company is engaged in discovering and developing drugs for indications with unmet medical needs in areas. Its lead clinical drug candidates include STP705 and STP707. Its STP705 is a multi-targeted siRNA therapeutic advancing clinical development across two oncology indications: squamous cell carcinoma in situ (isSCC) and basal cell carcinoma (BCC). Its STP707 is an intravenous siRNA therapeutic being evaluated in phase I clinical trial for multiple solid tumors, including colorectal, pancreatic, liver, and metastatic melanoma cancers. It is capitalizing on its dual delivery platforms, which include Polypeptide nanoparticle (PNP) and GalAhead.
Employees
-
Date Price Change Volume
26-09-04 HK$3.800 -3.55% 17,500
26-09-03 HK$3.940 0.00% 100
26-09-02 HK$3.940 +3.41% 31,950
26-09-01 HK$3.810 +1.06% 28,050
26-08-31 HK$3.770 -4.56% 79,750
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4846USD
Average target price
9.200USD
Spread / Average Target
+1,798.40%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2257 Stock